載入...
Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study
BACKGROUND. Immunosuppression with calcineurin inhibitors (CNIs) is reportedly associated with risk of renal impairment in liver transplant recipients. It is believed that this can be mitigated by decreasing initial exposure to CNIs or delaying CNI introduction until 3–4 d posttransplantation. The A...
Na minha lista:
| 發表在: | Transplant Direct |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Lippincott Williams & Wilkins
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8274734/ https://ncbi.nlm.nih.gov/pubmed/34263020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001166 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|